Abstract
Background: We report on the longterm follow-up of two patients with relapsing-remitting multiple sclerosis and concomitant chronic myeloid leukemia (CML) treated with allogeneic hematopoietic stem cell transplantation (HSCT).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have